Knee Surg Relat Res 2016 Sep; 28(3): 213-218  https://doi.org/10.5792/ksrr.2016.28.3.213
Incidences of Deep Vein Thrombosis and Pulmonary Embolism after Total Knee Arthroplasty Using a Mechanical Compression Device with and without Low-Molecular-Weight Heparin
Sin Hyung Park, MD, Joong Hyeon Ahn, MD, Yong Bok Park, MD, Sun Geun Lee, MD, and Soo Jae Yim, MD
Department of Orthopedic Surgery, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
Correspondence to: Soo Jae Yim, MD 
Department of Orthopaedic Surgery, Soonchunhyang University
Bucheon Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon 14584, Korea 
Tel: +82-32-621-5260, Fax: +82-32-621-5018 
Received: January 23, 2016; Revised: June 30, 2016; Accepted: July 16, 2016; Published online: September 1, 2016.
© Korean Knee Society. All rights reserved.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Purpose: To investigate the incidence of thromboembolic events and complications related to bleeding after total knee arthroplasty (TKA) with a mechanical compression device alone or in combination with low-molecular-weight heparin (LMWH). 
Materials and Methods: A total of 489 TKA patients (776 knees) were retrospectively reviewed for the incidence of thromboembolic events and complications related to bleeding. While 233 patients (354 knees) were treated with a mechanical compressive device without LMWH, 256 patients (422 knees) were treated with the mechanical compressive device along with LMWH. 
Results: The incidences of deep vein thrombosis (DVT) and pulmonary embolism (PE) were 15 of 375 knees (4.0%) and 5 of 375 knees (1.3%), respectively, in the group that used only a mechanical compressive device, and 14 of 401 knees (3.4%) and 5 of 401 knees (1.2%), respectively, in the group that used the mechanical compressive device with LMWH. There was no significant difference between the two groups (p=0.125 and p=0.146, respectively). The postoperative hemovac drainage amount was 635±57 mL in the group with a mechanical compressive device only and 813±84 mL in the group with the device and LMWH; therefore, the amount of drainage was significantly greater in the latter group (p=0.013). 
Conclusions: Mechanical compression alone for prophylaxis against DVT and PE after TKA can be an attractive option in Korean patients.
Keywords: Knee, Arthroplasty, Thromboembolism, Prophylaxis, Mechanical, Intermittent pneumatic compression device
References
  1. Parvizi J, Sullivan TA, Trousdale RT, Lewallen DG. Thirtyday mortality after total knee arthroplasty. J Bone Joint Surg Am. 2001;83:1157-61.
    Pubmed
  2. Howie C, Hughes H, Watts AC. Venous thromboembolism associated with hip and knee replacement over a tenyear period: a population-based study. J Bone Joint Surg Br. 2005;87:1675-80.
    Pubmed CrossRef
  3. Cohen AT. Long-term benefits of preventing venous thromboembolic events. Curr Med Res Opin. 2012;28:877-89.
    Pubmed CrossRef
  4. McRae SJ, Ginsberg JS. Initial treatment of venous thromboembolism. Circulation. 2004;110(9 Suppl 1):I3-9.
    Pubmed CrossRef
  5. Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ:what are the implications for clinicians and patients? Chest. 2009;135:513-20.
    Pubmed CrossRef
  6. Weinmann EE, Salzman EW. Deep-vein thrombosis. N Engl J Med. 1994;331:1630-41.
    Pubmed CrossRef
  7. Colwell CW Jr, Froimson MI, Anseth SD, Giori NJ, Hamilton WG, Barrack RL, Buehler KC, Mont MA, Padgett DE, Pulido PA, Barnes CL. A mobile compression device for thrombosis prevention in hip and knee arthroplasty. J Bone Joint Surg Am. 2014;96:177-83.
    Pubmed CrossRef
  8. Hull RD, Yusen RD, Bergqvist D. State-of-the-art review:assessing the safety profiles of new anticoagulants for major orthopedic surgery thromboprophylaxis. Clin Appl Thromb Hemost. 2009;15:377-88.
    Pubmed CrossRef
  9. Pidala MJ, Donovan DL, Kepley RF. A prospective study on intermittent pneumatic compression in the prevention of deep vein thrombosis in patients undergoing total hip or total knee replacement. Surg Gynecol Obstet. 1992;175:47-51.
    Pubmed
  10. Woolson ST, Watt JM. Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement: a prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. J Bone Joint Surg Am. 1991;73:507-12.
    Pubmed
  11. Kaempffe FA, Lifeso RM, Meinking C. Intermittent pneumatic compression versus coumadin: prevention of deep vein thrombosis in lower-extremity total joint arthroplasty. Clin Orthop Relat Res. 1991;(269):89-97.
    CrossRef
  12. Fuji T, Ochi T, Niwa S, Fujita S. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, doubleblind, placebo-controlled studies with three dosage regimens of enoxaparin. J Orthop Sci. 2008;13:442-51.
    Pubmed CrossRef
  13. Kim KI, Cho KY, Jin W, Khurana SS, Bae DK. Recent Korean perspective of deep vein thrombosis after total knee arthroplasty. J Arthroplasty. 2011;26:1112-6.
    Pubmed CrossRef
  14. Leizorovicz A, Turpie AG, Cohen AT, Wong L, Yoo MC, Dans A; SMART Study Group. Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis: the SMART study. J Thromb Haemost. 2005;3:28-34.
    Pubmed CrossRef
  15. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr; ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387-94.
    CrossRef
  16. Fujita S, Hirota S, Oda T, Kato Y, Tsukamoto Y, Fuji T. Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan. Clin Orthop Relat Res. 2000;(375):16874.
    CrossRef
  17. Sudo A, Sano T, Horikawa K, Yamakawa T, Shi D, Uchida A. The incidence of deep vein thrombosis after hip and knee arthroplasties in Japanese patients: a prospective study. J Orthop Surg (Hong Kong). 2003;11:174-7.
  18. Lieberman JR, Pensak MJ. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2013;95:1801-11.
    Pubmed CrossRef
  19. Jensen CD, Steval A, Partington PF, Reed MR, Muller SD. Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study. J Bone Joint Surg Br. 2011;93:91-5.
    Pubmed CrossRef
  20. Nagase Y, Yasunaga H, Horiguchi H, Hashimoto H, Shoda N, Kadono Y, Matsuda S, Nakamura K, Tanaka S. Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan. J Bone Joint Surg Am. 2011;93:e146.
    Pubmed CrossRef
  21. Kim YH, Kulkarni SS, Park JW, Kim JS. Prevalence of deep vein thrombosis and pulmonary embolism treated with mechanical compression device after total knee arthroplasty in Asian patients. J Arthroplasty. 2015;30:1633-7.
    CrossRef
  22. Kanchanabat B, Stapanavatr W, Meknavin S, Soorapanth C, Sumanasrethakul C, Kanchanasuttirak P. Systematic review and meta-analysis on the rate of postoperative venous thromboembolism in orthopaedic surgery in Asian patients without thromboprophylaxis. Br J Surg. 2011;98:1356-64.
    Pubmed CrossRef


e-submission

This Article

Archives

Indexed/Covered by